This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ulrich Brinkmann, Ph.D.
Expert Scientist, Large Molecule Research, Pharma Research & Early Development at Roche Innovation Center, Munich


Dr. Ulrich Brinkmann (PhD) is a member of Roche’s Large Molecule Research organization within Pharma Research & Early Development at the Roche Innovation Center Munich (Penzberg, Germany). His current work focuses on protein & antibody engineering, bispecifics, and on delivery platforms for targeted payload delivery. Before joining Roche, he served as CSO in functional genomics and pharmacogenetics companies Xantos and Epidauros. Prior to that, he focused on antibody stabilization and engineering technologies, and on generating recombinant immunotoxins for cancer therapy in Ira Pastans Molecular Biology Lab at the NIH/NCI in Bethesda.;

Agenda Sessions

  • Antibody-mediated Intracellular Delivery of Nucleic acids: Targeted Plasmid-chromatin

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #8: POTENTIATING ANTIBODIES THROUGH CONJUGATION - To prepare for this discussion/Q&A, attendees should view the presentations from Session #8 in the Watch On-Demand Sessions Tab prior to this session